Stay updated on Personalized Neoantigen Cancer Vaccine Clinical Trial
Sign up to get notified when there's something new on the Personalized Neoantigen Cancer Vaccine Clinical Trial page.

Latest updates to the Personalized Neoantigen Cancer Vaccine Clinical Trial page
- Check2 days agoChange DetectedThe page shows a revision update from v3.3.3 to v3.3.4; core study content and details appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded detailed trial locations, listing sites across Arizona, Florida, Illinois, Minnesota, New York, Ohio, Tennessee, Texas, Virginia, and Victoria, Australia. The revision version updated from v3.3.2 to v3.3.3.SummaryDifference1%

- Check52 days agoChange DetectedPublications section now states that entries are automatically filled from PubMed, and a new Revision: v3.3.2 label is shown; the previous PubMed wording and older revision label were removed.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved the general government funding and NIH operations notice; the page's study details and links remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check74 days agoChange DetectedCore study information appears unchanged between the screenshots. Only minor formatting adjustments are visible.SummaryDifference0.4%

- Check103 days agoChange DetectedUpdate to v3.2.0 with a government funding lapse notice and open status of NIH Clinical Center; removes v3.1.0.SummaryDifference4%

Stay in the know with updates to Personalized Neoantigen Cancer Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Personalized Neoantigen Cancer Vaccine Clinical Trial page.